Literature DB >> 16396646

Clinical characteristics of subretinal deposits in central serous chorioretinopathy.

Maria Wang1, Birgit Sander, Morten la Cour, Michael Larsen.   

Abstract

PURPOSE: To describe abnormal subretinal material in central serous chorioretinopathy (CSC).
DESIGN: Retrospective observational case series. PARTICIPANTS: 168 consecutive patients (336 eyes) with a definite diagnosis of serous foveal detachment attributable to CSC in one or both eyes, on one or more occasions.
METHODS: Review of all cases seen during a six-year period. Grading of the amount of subretinal material at presentation as absent, questionable, mild, moderate or severe.
RESULTS: Of 168 patients with CSC, 133 (79%) were men and 35 (21%) women. The median age was 45.2 years (range 22-70 yrs). The median duration of symptoms was 2 months (range 0.1-144 months). Subretinal material was found in the symptomatic eye or, in bilateral cases, in the eye that had most recently become symptomatic in 138 patients and in increasing amounts with increasing duration of symptoms (p < 0.001) but unrelated to age or sex. A substantial fraction of the material was shown by optical coherence tomography to be attached to the photoreceptor outer segments of the detached retina.
CONCLUSIONS: Increasing amounts of subretinal material are found with increasing duration of symptoms in eyes with CSC. This suggests that early granular deposits may be composed of fragments of photoreceptor outer segments that accumulate when the phagocytosis photoreceptor outer segment material is disrupted by the serous detachment of the retina. Other possible origins that cannot be excluded include plasma proteins excluding from the choriocapillaris, inflammatory debris, and lipid exudate originating from occult choroidal neovascularization secondary to CSC.

Entities:  

Mesh:

Year:  2005        PMID: 16396646     DOI: 10.1111/j.1600-0420.2005.00582.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  22 in total

1.  Central serous chorioretinopathy after blunt trauma.

Authors:  Claudia Maria Prospero Ponce; Hasan M Mohidat; Charles A Garcia
Journal:  BMJ Case Rep       Date:  2012-05-26

2.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

Review 3.  Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.

Authors:  Y-R Chung; E J Seo; H M Lew; K H Lee
Journal:  Eye (Lond)       Date:  2013-11-08       Impact factor: 3.775

Review 4.  The use of SD-OCT in the differential diagnosis of dots, spots and other white retinal lesions.

Authors:  Elena Zaharova; Jerome Sherman
Journal:  Eye Brain       Date:  2011-10-25

5.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

6.  Retinal sensitivity assessed by microperimetry and corresponding retinal structure and thickness in resolved central serous chorioretinopathy.

Authors:  H W Chung; C M Yun; J T Kim; S-W Kim; J Oh; K Huh
Journal:  Eye (Lond)       Date:  2014-08-01       Impact factor: 3.775

7.  Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy.

Authors:  Mehmet Yasin Teke; Ufuk Elgin; Pinar Nalcacioglu-Yuksekkaya; Emine Sen; Pinar Ozdal; Faruk Ozturk
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

8.  Retinal structure in young patients aged 10 years or less with Best vitelliform macular dystrophy.

Authors:  Patrik Schatz; Dror Sharon; Sermed Al-Hamdani; Sten Andréasson; Michael Larsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-05       Impact factor: 3.117

9.  Toxicity profiles of subretinal indocyanine green, Brilliant Blue G, and triamcinolone acetonide: a comparative study.

Authors:  Rasmus Ejstrup; M la Cour; S Heegaard; J F Kiilgaard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-16       Impact factor: 3.117

10.  Predicting visual outcomes for macular disease using optical coherence tomography.

Authors:  Pearse A Keane; Srinivas R Sadda
Journal:  Saudi J Ophthalmol       Date:  2011-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.